Consumer medicine information

Cadivast

Amlodipine + Atorvastatin

BRAND INFORMATION

Brand name

Cadivast

Active ingredient

Amlodipine + Atorvastatin

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Cadivast.

What is in this leaflet

This leaflet answers some common questions about Cadivast. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Cadivast against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

What Cadivast is used for

Cadivast is used to treat:

  • high blood pressure and high cholesterol (fat in the blood).
  • angina (a certain type of chest pain).
  • people who have high blood pressure and coronary heart disease (CHD) or who are at risk of CHD (for example, if they have diabetes, a history of stroke, or small blood vessel disease). In these people, Cadivast is used to help reduce the risk of having a heart attack or stroke.

Cadivast contains a combination of two medicines. One is amlodipine and the other is atorvastatin.

Amlodipine belongs to a group of medicines called calcium channel blockers. They work by relaxing your blood vessels, making it easier for your heart to pump blood around the body and help increase the supply of blood and oxygen to your heart. Calcium channel blockers do not change the amount of calcium in your blood or bones.

Atorvastatin belongs to a group of medicines called statins. It works by reducing the amount of cholesterol made by the liver. It reduces the 'bad' cholesterol and can raise the 'good' cholesterol. Atorvastatin also helps to protect you from a heart attack or stroke.

Cadivast may be used alone, or in combination with other medicines, to treat your condition.

Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed it for another reason.

This medicine is not addictive.

This medicine is available only with a doctor's prescription.

There is not enough information to recommend the use of this medicine for children.

Before you take Cadivast

When you must not take it

Do not take Cadivast if you have an allergy to:

  • any medicine containing amlodipine
  • any medicine containing atorvastatin
  • any of the ingredients listed at the end of this leaflet

Some of the symptoms of an allergic reaction may include:

  • shortness of breath
  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue or other parts of the body
  • rash, itching or hives on the skin

Do not take Cadivast if you have active liver disease.

Do not take this medicine if you are pregnant or intend to become pregnant.

If you are a woman of child-bearing age and are taking this medicine, use a proven method of birth control to avoid pregnancy. It may affect your developing baby if you take it during pregnancy.

Do not breast-feed if you are taking this medicine. This medicine may pass into breast milk and there is a possibility that your baby may be affected.

Do not take Cadivast if you are taking the antibiotic fusidic acid which is used to treat infections

Do not take Cadivast if you are taking the antivirals glecaprevir/pibrentasvir for the treatment of hepatitis C.

Do not give this medicine to children. Safety and effectiveness in children have not been established.

Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal.

If you are not sure whether you should start taking this medicine, talk to your doctor.

Before you start to take it

Your doctor will ask you to have your liver function tested before you start to take Cadivast.

Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.

Tell your doctor if you have or have had any of the following medical conditions:

  • heart disease such as heart failure
  • liver problems
  • kidney problems
  • muscle pain, tenderness or weakness from other medicines used to treat cholesterol or triglycerides
  • breathing problems
  • a type of stroke called a haemorrhagic stroke or a type of stroke called a lacunar stroke.

If you have had one of these strokes before, this medicine may increase the risk of you having a haemorrhagic stroke.

Tell your doctor if you are consuming alcohol regularly.

Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Your doctor can discuss with you the risks and benefits involved.

If you have not told your doctor about any of the above, tell him/her before you start taking Cadivast.

Taking other medicines

Tell your doctor or pharmacist if:

  • you are taking other calcium channel blockers. These medicines include amlodipine which is also in Cadivast; other calcium channel blockers include medicines with the active ingredient felodipine or nifedipine. Check with your doctor or pharmacist if you are unsure.
  • you are taking other statins. These medicines include atorvastatin which is also in Cadivast. Other statins include medicines with active ingredient fluvastatin, pravastatin, rosuvastatin, simvastatin or simvastatin containing medicines. Check with your doctor or pharmacist if you are unsure.

These medicines may be affected by Cadivast or may affect how well it works. You may need different amounts of your medicines, or you may need to take different medicines.

Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine.

Tell your doctor or pharmacist if you are taking any of the following:

  • digoxin, a medicine used to treat some heart problems
  • the antibiotics erythromycin, clarithromycin, rifampicin or fusidic acid
  • phenytoin, a medicine used to treat epilepsy (seizures)
  • oral contraceptives for birth control
  • other medicines to treat high cholesterol or triglycerides
  • other medicines to treat high blood pressure
  • some medicines to treat low potassium
  • ciclosporin, tacrolimus, sirolimus or everolimus, medicines used to suppress the immune system
  • temsirolimus, a medicine used to treat kidney cancer
  • some medicines used to treat some fungal infections, such as ketoconazole or itraconazole
  • protease inhibitors for the treatment of HIV infections and/or Hepatitis C, such as efavirenz, fosamprenavir, ritonavir, boceprevir, telaprevir, tipranavir/ritonavir, elbasvir/grazoprevir and simprevir
  • letermovir
  • diltiazem, a medicine used to treat angina
  • antacids, medicines used to treat reflux or ulcers
  • spironolactone, a medicine used to treat high blood pressure and certain types of swelling
  • vitamin B3
  • colchicine, a medicine used to treat a disease with painful swollen joints caused by uric acid crystals

It is also possible that Cadivast may be affected by some medicines used to treat heart palpitations (or arrhythmias) and St John's Wort.

Your doctor and pharmacist have more information on medicines to be careful with or to avoid while taking Cadivast.

If you have not told your doctor about any of the above, tell him/her before you start taking Cadivast.

How to take Cadivast

Take Cadivast exactly as your doctor has prescribed.

Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet.

Your doctor may discuss with you the need to be on a diet.

Follow your agreed diet plan carefully.

If you do not understand the instructions on the box/bottle, ask your doctor or pharmacist for help.

How much to take

Cadivast is taken once a day. Your doctor will decide which strength is suitable for you. This will depend on your blood pressure, cholesterol and triglyceride levels.

Your doctor may need to adjust your dose after your blood pressure and the fat levels in your blood have been checked. It is important that you keep your appointments to have these tests done.

How to take it

Swallow the tablets whole with a full glass of water.

Do not crush or chew the tablets.

When to take it

Take your medicine at about the same time each day. Taking it at the same time each day will have the best effect. It will also help you remember when to take it.

It does not matter if you take this medicine before or after food.

How long to take it

Take Cadivast every day and continue taking it for as long as your doctor tells you.

Continue taking your medicine for as long as your doctor tells you.

This medicine to lower cholesterol levels and blood pressure and control the symptoms of angina but it does not cure your condition.

It is important to keep taking your medicine even if you feel well. If you stop taking Cadivast, your blood pressure and cholesterol levels may rise again.

If you forget to take it

If it is less than 12 hours before your next dose, skip the dose you missed and take your next dose when you are meant to.

Otherwise, take it as soon as you remember, and then go back to taking your medicine as you would normally.

Do not take a double dose to make up for the dose that you missed. This may increase the chance of you getting an unwanted side effect.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering to take your medicine, ask your pharmacist for some hints.

If you take too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre (telephone 13 11 26) for advice, or go to Accident and Emergency at the nearest hospital, if you think that you or anyone else may have taken too much Cadivast. Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

Keep telephone numbers of these facilities handy.

Symptoms of an overdose may include dizzy, lightheaded or faint and have an irregular heartbeat.

While you are using Cadivast

Things you must do

If you are about to be started on any new medicine, remind your doctor and pharmacist that you are taking Cadivast.

Tell any other doctors, dentists, and pharmacists who treat you that you are taking this medicine.

If you are going to have surgery, tell the surgeon or anaesthetist that you are taking this medicine. It may affect other medicines used during surgery.

If you become pregnant while taking this medicine, tell your doctor immediately.

If you are about to have any blood tests, tell your doctor that you are taking this medicine. It may interfere with the results of some tests.

Keep all of your doctor's appointments so that your progress can be checked. Your cholesterol and triglyceride levels and your liver function tests need to be checked regularly while you are taking this medicine.

A regular blood test to check an enzyme called creatine kinase (CK) may be needed. CK in your blood can rise after muscle injury which can be caused by medicines used to treat cholesterol or triglycerides, such as Cadivast.

This helps to make sure that Cadivast is working and to avoid some possible side-effects.

Your blood pressure may also be checked regularly.

Things you must not do

Do not take Cadivast to treat any other complaints unless your doctor tells you to.

Do not give your medicine to anyone else, even if they have the same condition as you.

Do not stop taking your medicine or lower the dosage without checking with your doctor. If you stop taking it suddenly, your condition may worsen or you may have unwanted side effects such as.

Things to be careful of

Avoid drinking large quantities of alcohol. Drinking large quantities of alcohol while taking Cadivast may increase your chance of getting liver problems.

Avoid eating large quantities of grapefruit or drinking large quantities of grapefruit juice. Grapefruit juice contains one or more components that alter the metabolism of some medicines, including Cadivast.

Drinking very large quantities (over 1.2 litres) of grapefruit juice each day while taking Cadivast increases your chance of getting side effects.

Be careful driving or operating machinery until you know how Cadivast affects you. This medicine may cause dizziness or drowsiness in some people and affect alertness.

If you have any of these symptoms, do not drive, operate machinery or do anything else that could be dangerous.

If you feel light-headed, dizzy or faint when getting out of bed or standing up, get up slowly. Standing up slowly, especially when you get up from bed or chairs, will help your body get used to the change in position and blood pressure. If this problem continues or gets worse, talk to your doctor.

Lifestyle measures that help reduce heart disease risk

By following these simple measures, you can further reduce the risk from heart disease.

  • Quit smoking and avoid second-hand smoke.
  • Limit alcohol intake.
  • Enjoy healthy eating by:
    - Eating plenty of vegetables and fruit;
    - Reducing your saturated fat intake (eat less fatty meats, full fat dairy products, butter, coconut and palm oils, most take-away foods, commercially-baked products).
    - Reducing your salt intake
  • Be active. Progress, over time, to at least 30 minutes of moderate-intensity physical activity on 5 or more days each week. Can be accumulated in shorter bouts of 10 minutes duration. If you have been prescribed anti-angina medicine, carry it with you when being physically active.
  • Maintain a healthy weight.
  • Discuss your lifestyle and lifestyle plans with your doctor.
  • For more information and tools to improve your heart health, call Heartline, the Heart Foundation's national telephone information service, on 1300 36 27 87 (local call cost).

Know warning signs of heart attack and what to do:

  • Tightness, fullness, pressure, squeezing, heaviness or pain in your chest, neck, jaw, throat, shoulders, arms or back.
  • You may also have difficulty breathing, or have a cold sweat or feel dizzy or light headed or feel like vomiting (or actually vomit).
  • If you have heart attack warning signs that are severe, get worse or last for 10 minutes even if they are mild, call triple zero (000). Every minute counts.

Side effects

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Cadivast.

This medicine helps most people with lowering high blood pressure and high cholesterol but it may have unwanted side effects in some people.

All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side effects.

If you are over 65 years of age you may have an increased chance of getting side effects.

Do not be alarmed by the following lists of side effects. You may not experience any of them.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor or pharmacist if you notice any of the following and they worry you:

  • headache
  • flushing
  • dizziness
  • tiredness or weakness
  • drowsiness or sleepiness
  • stomach pain or nausea (feeling sick)
  • constipation, diarrhoea, wind
  • heartburn, indigestion or wind
  • urine infection
  • stuffy or runny nose
  • nose bleeds
  • rash

The above list includes the more common side effects of your medicine. They are usually mild and short-lived.

Tell your doctor as soon as possible if you notice any of the following:

  • swelling of the ankles, feet, face or hands
  • muscle and joint pain, muscle weakness, especially in the forearms, thighs, hips, shoulders, neck, and back
  • difficulty climbing stairs or standing up from a chair
  • difficulty lifting arms over the head
  • falling and difficulty getting up from a fall
  • symptoms of liver disease such as itching, yellowing of the skin and eyes and dark coloured urine
  • feeling weak and tired, excessively thirsty and passing more urine
  • dizziness or lightheadedness on standing up from a sitting or lying position
  • problems with breathing, including shortness of breath, persistent cough and fever
  • eye pain or change in vision
  • changes in mood, feeling anxious or nervous

The above list includes serious side effects that may require medical attention.

If any of the following happen, tell your doctor immediately or go to Accident and Emergency at your nearest hospital:

  • symptoms of allergy such as skin rash, itching, swelling of the face, lips, mouth, throat or neck which may cause difficulty in swallowing and breathing
  • shortness of breath
  • unexpected muscle pain, tenderness or weakness not caused by exercise, particularly if you also feel unwell or have a fever
  • tingling in the hands or feet
  • changes in heart beat either fast, slow or irregular
  • chest pain associated with exertion (angina) that lasts longer, is more severe or occurs more often
  • chest pain
  • sudden severe headache, which may be accompanied by nausea, vomiting, loss of sensation, tingling in any part of the body or ringing in the ears
  • severe blisters and bleeding of the lips, eyes, mouth, nose or genitals
  • severe upper stomach pain, often with nausea and vomiting.

The above list includes very serious side effects. You may need urgent medical attention or hospitalisation.

Tell your doctor or pharmacist if you notice anything that is making you feel unwell.

Other side effects not listed above may also occur in some people.

Ask your doctor or pharmacist to answer any questions you may have.

If you are 65 years or older, you should be especially careful while taking Cadivast. Report any side effects promptly to your doctor.

Some people in this age group maybe more likely to experience side effects such as swelling of the feet and ankles, muscle cramps and dizziness.

Tell your doctor or pharmacist if you notice anything else that is making you feel unwell. Other side effects not listed above may also occur in some people.

After using Cadivast

Storage

Keep your tablets in the pack until it is time to take them. If you take the tablets out of the pack they may not keep well.

Keep your tablets in a cool dry place where the temperature stays below 25°C.

Do not store Cadivast or any other medicine in the bathroom or near a sink. Do not leave it on a window sill or in the car. Heat and dampness can destroy some medicines.

Keep it where children cannot reach it. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Disposal

If your doctor tells you to stop taking this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.

Product description

What it looks like

Cadivast tablets are available in eight strengths:

  • Cadivast 5/10 - A white to off-white, film-coated, oval, biconvex tablet debossed with "AA 4" on one side of the tablet and "M" on the other side.
  • Cadivast 5/20 - A white to off-white, film-coated, round, biconvex tablet debossed with "AA 5" on one side of the tablet and "M" on the other side.
  • Cadivast 5/40 - A white to off-white, film-coated, capsule shaped, biconvex tablet debossed with "AA 6" on one side of the tablet and "M" on the other side.
  • Cadivast 5/80 - A white to off-white, film-coated, oval, biconvex tablet debossed with "AA 7" on one side of the tablet and "M" on the other side.
  • Cadivast 10/10 - A blue, film-coated, barrel shaped, biconvex tablet debossed with "AA 8" on one side of the tablet and "M" on the other side.
  • Cadivast 10/20 - A blue, film-coated, oval, biconvex tablet debossed with "AA 9" on one side of the tablet and "M" on the other side.
  • Cadivast 10/40 - A blue, film-coated, round, biconvex tablet debossed with "AA 10" on one side of the tablet and "M" on the other side.
  • Cadivast 10/80 - A blue, film-coated, capsule shaped, biconvex tablet debossed with "AA 11" on one side of the tablet and "M" on the other side.

Each bottle pack contains 30 tablets.

Ingredients

Cadivast tablets contain the following strength combinations of the active ingredients amlodipine/atorvastatin:

  • 5 mg/10 mg
  • 5 mg/20 mg
  • 5 mg/40 mg
  • 5 mg/80 mg
  • 10 mg/10 mg
  • 10 mg/20 mg
  • 10 mg/40 mg
  • 10 mg/80 mg

It also contains the following inactive ingredients:

  • colloidal anhydrous silica
  • sodium carbonate
  • microcrystalline cellulose
  • arginine
  • pregelatinised maize starch
  • croscarmellose sodium
  • hyprolose
  • magnesium stearate
  • Opadry AMB white OY-B-28920
    or
  • Opadry AMB blue 80W10932

This medicine does not contain lactose, sucrose, gluten, tartrazine or any other azo dyes.

Supplier

Cadivast is supplied in Australia by:

Alphapharm Pty Ltd
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
www.mylan.com.au

Australian registration numbers:

Cadivast 5 /10:
AUST R 199213

Cadivast 5/20:
AUST R 199222

Cadivast 5/40:
AUST R 199214

Cadivast 5/80:
AUST R 199210

Cadivast 10/10:
AUST R 199215

Cadivast 10/20:
AUST R 199223

Cadivast 10/40:
AUST R 199225

Cadivast 10/80:
AUST R 199217

This leaflet was prepared in November 2019.

Cadivast_cmi\Nov19/00

Published by MIMS December 2019

BRAND INFORMATION

Brand name

Cadivast

Active ingredient

Amlodipine + Atorvastatin

Schedule

S4

 

1 Name of Medicine

Amlodipine (as besilate) and atorvastatin (as calcium trihydrate).

2 Qualitative and Quantitative Composition

The active ingredients in Cadivast are amlodipine besilate and atorvastatin calcium trihydrate.
Excipients with known effect. Soya bean products.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Cadivast 5/10 tablets. A white to off-white, film-coated, oval, biconvex tablet debossed with "AA 4" on one side of the tablet and "M" on the other side.
Cadivast 5/20 tablets. A white to off-white, film-coated, round, biconvex tablet debossed with "AA 5" on one side of the tablet and "M" on the other side.
Cadivast 5/40 tablets. A white to off-white, film-coated, capsule shaped, biconvex tablet debossed with "AA 6" on one side of the tablet and "M" on the other side.
Cadivast 5/80 tablets. A white to off-white, film-coated, oval, biconvex tablet debossed with "AA 7" on one side of the tablet and "M" on the other side.
Cadivast 10/10 tablets. A blue, film-coated, barrel shaped, biconvex tablet debossed with "AA 8" on one side of the tablet and "M" on the other side.
Cadivast 10/20 tablets. A blue, film-coated, oval, biconvex tablet debossed with "AA 9" on one side of the tablet and "M" on the other side.
Cadivast 10/40 tablets. A blue, film-coated, round, biconvex tablet debossed with "AA 10" on one side of the tablet and "M" on the other side.
Cadivast 10/80 tablets. A blue, film-coated, capsule shaped, biconvex tablet debossed with "AA 11" on one side of the tablet and "M" on the other side.

4 Clinical Particulars

4.9 Overdose

Symptoms. There is no information on overdoses with amlodipine besilate and atorvastatin calcium trihydrate tablet.
Available data suggest that amlodipine besilate and atorvastatin calcium trihydrate tablet overdose, due to its CCB component, might be expected to cause excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. Dysrhythmias may occur following overdose with any calcium antagonist. Hypotension and bradycardia are usually seen within 1 to 5 hours following amlodipine overdose. Hypotension can persist for longer than 24 hours despite treatment. Cardiac rhythm disturbances have been noted to persist for up to 7 days. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.
Treatment. If massive amlodipine besilate and atorvastatin calcium trihydrate tablet overdose should occur, active cardiac and respiratory monitoring should be instituted. Frequent blood pressure measurements are essential. Should hypotension occur, cardiovascular support, including elevation of the extremities, and the judicious administration of fluids should be initiated. If hypotension remains unresponsive to these conservative measures, administration of vasopressors should be considered with attention to circulating volume and urine output. Intravenous calcium may help to reverse the effects of calcium entry blockade. In symptomatic patients, monitor serum creatinine, BUN, creatinine kinase, urine myoglobin for indications of renal impairment secondary to rhabdomyolysis and liver function tests.
If there has been significant ingestion, consider administration of activated charcoal. Administration of activated charcoal to healthy volunteers immediately or up to 2 hours after ingestion of amlodipine 10 mg has been shown to significantly decrease amlodipine absorption. In patients who are not fully conscious or have impaired gag reflex, consideration should be given to administering activated charcoal via nasogastric tube once the airway is protected. Ipecac emesis is not recommended since haemodynamic instability and CNS depression may rapidly develop. As both amlodipine and atorvastatin are highly protein bound, dialysis is not likely to be of benefit. For atorvastatin induced rhabdomyolysis, administer sufficient 0.9% saline to maintain urine output of 2 to 3 mL/kg/hr. Diuretics may be necessary to maintain urine output. Urinary alkalinisation is not routinely recommended.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. There are no genotoxicity or carcinogenicity studies with the amlodipine/atorvastatin combination.
Amlodipine. Amlodipine did not induce gene mutation in bacteria and mouse lymphoma cells; nor did it induce chromosome aberrations in human lymphocytes or Chinese hamster V79 fibroblast cells (in vitro) and in mouse bone marrow cells (in vivo).
Atorvastatin. Atorvastatin did not demonstrate mutagenic or clastogenic potential in an appropriate battery of assays. It was negative in the Ames test with Salmonella typhimurium and Escherichia coli, and in the in vitro HGPRT forward mutation assay in Chinese hamster lung cells. Atorvastatin did not produce significant increases in chromosomal aberrations in the in vitro Chinese hamster lung cell assay and was negative in the in vivo mouse micronucleus test.
Carcinogenicity. There are no carcinogenicity studies with amlodipine/ atorvastatin combination.
Amlodipine. The carcinogenic potential of amlodipine has not been fully elucidated. Amlodipine did not induce any tumours when tested in mice or rats at oral doses up to 2.5 mg/kg. This dose gave rise to plasma levels that are similar to or below those achieved clinically.
Atorvastatin. In a 2-year study in rats given 10 mg/kg/day, 30 mg/kg/day or 100 mg/kg/day, the incidence of hepatocellular adenoma was marginally, although not significantly, increased in females at 100 mg/kg/day. The maximum dose used was 11 times higher than the highest human dose (80 mg/day) based on AUC (0-24) values. In a 2 year study in mice given 100 mg/kg, 200 mg/kg or 400 mg/kg, incidences of hepatocellular adenoma in males and hepatocellular carcinoma in females were increased at 400 mg/kg/day. The maximum dose used was 14 times higher than the highest human dose (80 mg/day) based on AUC (0-24) values. Other HMG-CoA reductase inhibitors have been reported to induce hepatocellular tumours in mice and rats.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Amlodipine. Chemical name: 3-ethyl, 5-methyl (4RS)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzene sulfonate.
Molecular formula: C20H25ClN2O5.C6H6O3S.
Molecular weight: 567.1.
Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSAMBESI.gif CAS number. CAS registry no.: 111470-99-6.
Atorvastatin calcium trihydrate. Chemical name: (3R, 5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate calcium trihydrate.
Molecular formula: C66H68CaF2N4O10.3H2O.
Molecular weight: 1209.39.
Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSATOCAT.gif CAS number. CAS registry no.: 344423-98-9.
Amlodipine besilate is white or almost white powder. Atorvastatin calcium trihydrate is white or almost white powder. Amlodipine besilate is slightly soluble in water, freely soluble in methanol, sparingly soluble in anhydrous ethanol and slightly soluble in 2-propanol. Atorvastatin calcium trihydrate slightly soluble in water, slightly soluble in ethanol (96%), and practically insoluble in methylene chloride.

7 Medicine Schedule (Poisons Standard)

S4.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/CADIVAST.gif